Coronary Embolism: A Systematic Review
- PMID: 31178350
- DOI: 10.1016/j.carrev.2019.05.012
Coronary Embolism: A Systematic Review
Abstract
Background: Coronary embolism is a rare and potentially fatal phenomenon that occurs primarily in patients with valvular heart disease and atrial fibrillation. There is a lack of consensus regarding the diagnosis, treatment, and management of coronary embolism, leaving management at the discretion of the treating physician. Through this review, we aim to establish a better understanding of coronary embolism, and to identify treatment options - invasive and non-invasive - that may be used to manage coronary embolism.
Methods and results: Our systematic review included 147 documented cases of coronary embolism from case reports and case series. The average age of our population was 54.2 ± 17.6 years. The most common causes of coronary embolism included infective endocarditis (22.4%), atrial fibrillation (17.0%), and prosthetic heart valve thrombosis (16.3%). Initial presentation was indistinguishable from an acute coronary syndrome (ACS) due to coronary atherosclerosis, and the diagnosis required a high level of suspicion and evaluation with angiography. Treatment strategies included, but were not limited to, thrombectomy, thrombolysis, balloon angioplasty and stent placement. Myocardial dysfunction on echocardiography was observed in over 80% of patients following coronary embolism. "Good outcomes" were reported in 68.7% of case reports and case series, with a mortality rate of 12.9%.
Conclusion: Coronary embolism is an under-recognized etiology of myocardial infarction with the potential for significant morbidity and mortality. To improve outcomes, physicians should strive for early diagnosis and intervention based on the underlying etiology. Thrombectomy may be considered with the goal of rapid restoration of coronary flow.
Copyright © 2019 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest Dr. Deepak L. Bhatt discloses the following relationships — Advisory Board: Cardax, Elsevier Practice Update Cardiology, Medscape Cardiology, Regado Biosciences; Board of Directors: Boston VA Research Institute, Society of Cardiovascular Patient Care, TobeSoft; Chair: American Heart Association Quality Oversight Committee; Data Monitoring Committees: Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute, for the PORTICO trial, funded by St. Jude Medical, now Abbott), Cleveland Clinic, Duke Clinical Research Institute, Mayo Clinic, Mount Sinai School of Medicine (for the ENVISAGE trial, funded by Daiichi Sankyo), Population Health Research Institute; Honoraria: American College of Cardiology (Senior Associate Editor, Clinical Trials and News, ACC.org; Vice-Chair, ACC Accreditation Committee), Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute; RE-DUAL PCI clinical trial steering committee funded by Boehringer Ingelheim), Belvoir Publications (Editor in Chief, Harvard Heart Letter), Duke Clinical Research Institute (clinical trial steering committees), HMP Global (Editor in Chief, Journal of Invasive Cardiology), Journal of the American College of Cardiology (Guest Editor; Associate Editor), Population Health Research Institute (for the COMPASS operations committee, publications committee, steering committee, and USA national co‑leader, funded by Bayer), Slack Publications (Chief Medical Editor, Cardiology Today's Intervention), Society of Cardiovascular Patient Care (Secretary/Treasurer), WebMD (CME steering committees); Other: Clinical Cardiology (Deputy Editor), NCDR-ACTION Registry Steering Committee (Chair), VA CART Research and Publications Committee (Chair); Research Funding: Abbott, Amarin, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi, Eisai, Ethicon, Forest Laboratories, Idorsia, Ironwood, Ischemix, Lilly, Medtronic, PhaseBio, Pfizer, Regeneron, Roche, Sanofi Aventis, Synaptic, The Medicines Company; Royalties: Elsevier (Editor, Cardiovascular Intervention: A Companion to Braunwald's Heart Disease); Site Co-Investigator: Biotronik, Boston Scientific, St. Jude Medical (now Abbott), Svelte; Trustee: American College of Cardiology; Unfunded Research: FlowCo, Merck, Novo Nordisk, PLx Pharma, Takeda. Dr. Kalra is a consultant to Medtronic and Philips. The remaining authors have no disclosures.
Similar articles
-
Left ventricular mural thrombus and dual coronary embolization associated with hyperthyroid cardiomyopathy and atrial fibrillation: a case report.BMC Cardiovasc Disord. 2017 May 19;17(1):128. doi: 10.1186/s12872-017-0565-7. BMC Cardiovasc Disord. 2017. PMID: 28525971 Free PMC article.
-
Complementary role of cardiac computed tomography angiography in the diagnosis of prosthetic aortic valve endocarditis and septic coronary embolism - a case report.J Radiol Case Rep. 2019 Feb 28;13(2):9-14. doi: 10.3941/jrcr.v13i2.3464. eCollection 2019 Feb. J Radiol Case Rep. 2019. PMID: 31565167 Free PMC article.
-
Septic coronary artery embolism treated with aspiration thrombectomy: case report and review of literature.Tex Heart Inst J. 2014 Aug 1;41(4):437-9. doi: 10.14503/THIJ-13-3386. eCollection 2014 Aug. Tex Heart Inst J. 2014. PMID: 25120402 Free PMC article. Review.
-
Coronary embolism causing acute inferior wall and ventricular myocardial infarction in a patient with rheumatic valvular heart disease: treatment with thrombus aspiration.Heart Surg Forum. 2015 Jun 26;18(3):E084-7. doi: 10.1532/hsf.1321. Heart Surg Forum. 2015. PMID: 26115148
-
Prosthetic Aortic Valve Thrombosis Complicated by Left Main Coronary Artery Bifurcation Embolism: Case Report and Review of Literature.Cardiovasc Revasc Med. 2021 Jul;28S:72-74. doi: 10.1016/j.carrev.2021.03.021. Epub 2021 Apr 6. Cardiovasc Revasc Med. 2021. PMID: 33863659 Review.
Cited by
-
Diagnostic Puzzles and Cause-Targeted Treatment Strategies in Myocardial Infarction with Non-Obstructive Coronary Arteries: An Updated Review.J Clin Med. 2023 Sep 26;12(19):6198. doi: 10.3390/jcm12196198. J Clin Med. 2023. PMID: 37834842 Free PMC article. Review.
-
Acute Myocardial Infarction: Etiologies and Mimickers in Young Patients.J Am Heart Assoc. 2023 Sep 19;12(18):e029971. doi: 10.1161/JAHA.123.029971. Epub 2023 Sep 19. J Am Heart Assoc. 2023. PMID: 37724944 Free PMC article. Review.
-
Atrial Fibrillation Related Coronary Embolism: Diagnosis in the Focus.J Pers Med. 2023 Apr 30;13(5):780. doi: 10.3390/jpm13050780. J Pers Med. 2023. PMID: 37240950 Free PMC article.
-
Typical clinical presentation of acute myocardial infarction and confusing coronary angiography: A case report and literature review of coronary embolism.Medicine (Baltimore). 2023 May 12;102(19):e33782. doi: 10.1097/MD.0000000000033782. Medicine (Baltimore). 2023. PMID: 37171301 Free PMC article. Review.
-
Contemporary Diagnosis and Management of Patients with MINOCA.Curr Cardiol Rep. 2023 Jun;25(6):561-570. doi: 10.1007/s11886-023-01874-x. Epub 2023 Apr 17. Curr Cardiol Rep. 2023. PMID: 37067753 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
